Full Length Research Paper
References
Angamo MT, Wabe NT (2012). Knowledge, Attitude and Practice of Adverse Drug Reaction reporting among health professionals in South West Ethiopia. TAF. Prev. Med. Bull. 11(4):397-406 |
|
Ernst FR, Grizzle AJ (2001). Drug related Morbidity and Mortality: Updating the cost of illness Model. J. Am. Pharm. Assoc. (Wash). 41(2):192-199. |
|
Herdeiro MT, Figueiras A, Polonia J, Gestal-Otero JJ (2006). Influence of pharmacists' attitudes on adverse drug reaction reporting: a case-control study in Portugal. Drug Saf. 29(4):331-340. |
|
Kamtane RA, Jayawardhani V (2012). Knowledge, attitude and perception of physicians towards adverse drug reaction (ADR) reporting: A pharmacoepidemiological study. Asian J. Pharm. Clin. Res. 5(3):210-214. |
|
Kazeam A, Jacob O (2009). Perceptions of Doctors to Adverse Drug Reaction reporting in a teaching Hospital in Lagos, Nigeria. BMC Clin. Pharmacol. 9:14. |
|
Kohn LT, Corrigan JM, Donaldson MS (2000). To err is human: building a safer health system (Vol. 6). National Academies Press. |
|
Lazarou J, Pomeranz BH, Corey PN (1998). Incidence of Adverse Drug Events in Hospitalized Patients: A Meta-analysis of prospective studies. JAMA 279(15):1200-1205. |
|
Lundkvist J, Jönsson B. (2004). Pharmacoeconomics of adverse drug reactions. Fundam. Clin. Pharmacol. 18(3):275-280. |
|
Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ (1981). A method for estimating probability of adverse drug reactions. Clin. Pharmacol. Ther. 30(2):239-245. |
|
Parker CW (1983). Allergic reaction in man. Pharmacol. Rev. 34:85-194. |
|
Rawlings MD, Thompson JP (1977). Pathogenesis of adverse drug reactions. Textbook of adverse drug reactions. Oxford University Press, Oxford. 44p. |
|
Rehans H, Vasudeuk T (2002). Knowledge, attitude and practices of medical students and prescribers on adverse drug reaction monitoring. Natl. Med. J. India 15(1):24-26. |
|
Santosh KC, Pramote T, Sarun G, Ralph E (2013). Attitudes among health care professionals to the reporting of adverse drug reaction in Nepal. BMC Pharmacol. Toxicol.14:16. |
|
Toklu HZ, Uysal MK (2008). Knowledge and Attitude of Turkish community pharmacists towards Pharmacovigilance in the Kadikoy district of Istanbul. Pharm World Sci. 30(5):556-562. |
|
Wiffen P, Gill M, Edwards J, Moore A (2002). Adverse drug reactions in hospital patients: a systematic review of the prospective and retrospective studies. Bandolier Extra 101(4):1-15. |
|
World Health Organization (1972). International drug monitoring: The role of national centers. WHO technical report. Geneva: Switzerland. |
|
World Health Organization (2000). Safety monitoring of medicinal products: guidelines for setting up and running a pharmacovigilance centre. Uppsala: UppsalaMonitoring Centre. |
|
World Health Organization (2001). A Guide line to detecting and reporting adverse drug reaction. WHO report Geneva: Switzerland. |
|
World Health Organization (2006). The Safety of Medicines in Public Health Programmes: Pharmacovigilance and essential tool. Geneva: Switzerland. |
|
Wysowski DK, Swartz L. (2005). Adverse drug event surveillance and drug withdrawls in United states, 1969-2002. Importance of reporting suspected reactions. Arch. Intern. Med. 165(12):1363-1369. |
|
Zolezzi M, Parsotam N (2005). Adverse drug reporting in New Zeeland: Implications for Pharmacists. Ther. Clin. Risk. Manage. 1(3):181-188 |
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0